Fan YH, Shi Y, Liu SF, Mao RF, An L, Zhao YL, Zhang H, Zhang F, Xu G-T*, Qin J*, Yang JH*. Lys48-linked TAK1 poly-ubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation. Cellular Signalling 2012; 24:1381-9. (*Co-corresponding authors)

Endler A*, Chen L, Zhang J, Xu G-T* and Futoshi Shibasaki. Binding of the ERα and ARNT1 AF2 domains to exon 21 of the SRC1 isoform SRC1e is essential for estrogen- and dioxin-related transcription.  J Cell Sci 2012; 125:2004-16. (*Co-corresponding authors)

Zhang JF, Xu GX, Zhang LM, Gu LM, Xu H, Lu LX, Wang J, Gao FR, Xu J-Y, Wang F, Li W*, Xu G-T*. A modified histoimmunochemistry-assisted method for in situ RPE evaluation. Frontiers in Bioscience 2012; 4:1571-81. (*Co-corresponding authors)

Hu L-M, Luo Y, Zhang JF, Lei X, Shen JF, Wu YL, Qin M, Yaprak Banu Unver, Zhong Y, Xu G-T*, Li W*. EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells. Frontiers in Bioscience 2011; 3:1541-55. (*Co-corresponding authors) 

Lei X, Zhang JF, Shen JF, Hu LM, Wu YL, Mou LS, Xu GX, Li W*, Xu G-T*. EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy. Frontiers in Bioscience (Elite Ed) 2011; 3:201-211. (*Co-corresponding authors)

Ma B, Lei X, Guan Y, Mou L-S, Yuan Y-F, Yue H, Lu Y, Xu G-T, Jiang Qian. Maintenance of retinal cancer stem cell-like properties through long-term serum-free culture from human retinoblastoma. ONCOLOGY reports 2011; 26:135-143

Zhang Y, Zhang J, Wang Q, Lei X, Chu Q, Xu G-T*, Ye W*: Intravitreal Injection of Exendin-4 Analogue Protects Retinal Cells in Early Diabetic Rats. Invest Ophthalmol Vis Sci 2011; 52:278-285. (*Co-corresponding authors)

Chu Q, Zhang J, Wu Y, Zhang Y, Xu G, Li W, Xu G-T*: The Differential Gene Expression Pattern of Diabetic Rat Retinas after Intravitreal Injection of Erythropoietin. Clinical and Experimental Ophthalmology 2010; 39:142-151. (Corresponding author)

Li W*, Sinclair SH*, Xu G-T*: Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular edema, Ophthalmic Surg Lasers Imaging 2010; 41:18-25 (*Co-coresponding authors)

Zhang J, Hu L, Xu G, Wu Y, Shen J, Luo Y, Zhong Y, Sinclair SH, Yanoff M, Li W*, Xu G-T*: Anti-VEGF effects of intravitreal erythropoietin in early diabetic retinopathy. Front Biosci (Elite Ed) 2010; 2:912-927. (*Co-corresponding authors)

Shen J, Wu Y, Xu JY, Zhang J, Sinclair SH, Yanoff M, Xu G, Li W*, Xu G-T*: ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Invest Ophthalmol Vis Sci 2010; 51:35-46. (*Co-corresponding authors)

Mou L, Xu JY, Li W, Lei X, Wu Y, Xu G, Kong X, Xu G-T*: Identification of vimentin as a novel target of HSF4 in lens development and cataract by proteomic analysis. Invest Ophthalmol Vis Sci 2010; 51:396-404. (*Corresponding author)

Xu JY, Su Y, Cheng JS, Li SX, Liu R, Li W, Xu G-T*, Li QN*, Protective effects of fullerenol on carbon tetrachloride-induced acute hepatotoxicity and nephrotoxicity in rats. Carbon 2010; 48:1388-1396. ( *Co-corresponding authors) 

Su Y, Xu JY, Shen P, Li J, Wang L, Li Q, Li W, Xu G-T, Fan C, Huang Q. Cellular uptake and cytotoxic evaluation of fullerenol in different cell lines. Toxicology. 2010; 269(2-3):155-9.

Xu JY, Han K, Li SX, Cheng JS, Xu G-T, Li WX, Li QN. Pulmonary responses to polyhydroxylated fullerenols, C(60)(OH)(x). J Appl Toxicol. 2009; 29:578-84.

Zhang Y, Wang Q, Zhang J, Lei X, Xu G-T*, Ye W*: Protection of exendin-4 analogue in early experimental diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2009; 247:699-706. (*Co-corresponding authors)

Zhang Q, Zhang J, Guan Y, Zhang S, Zhu C, Xu G-T*, Wang L*: Suppression of retinal neovascularization by the iNOS inhibitor aminoguanidine in mice of oxygen-induced retinopathy. Graefes Arch Clin Exp Ophthalmol 2009; 247:919-927. (*Co-corresponding authors)

Xiao YQ, Liu K, Shen JF, Xu G-T*, Ye W*: SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Invest Ophthalmol Vis Sci 2009; 50:1698-1706. (*Co-corresponding authors)

Xiao W, Wu Y, Zhang J, Ye W*, Xu G-T*: Selecting highly sensitive non-obese diabetic mice for improving the study of Sjogren's syndrome. Graefes Arch Clin Exp Ophthalmol 2009; 247:59-66. (*Co-corresponding authors)

Wang Z, Xu G-T, Wu Y, Guan Y, Cui L, Lei X, Zhang J, Mou L, Sun B, Dai Q: Neuregulin-1 enhances differentiation of cardiomyocytes from embryonic stem cells. Med Biol Eng Comput 2009; 47:41-48.

Shi X, Cui B, Wang Z, Weng L, Xu Z, Ma J, Xu G-T, Kong X, Hu L: Removal of Hsf4 leads to cataract development in mice through down-regulation of gamma S-crystallin and Bfsp expression. BMC Mol Biol 2009; 10:10

Li Q, Zhang J, Wang Y, Xu G-T: Molecular spectral imaging system for quantitative immunohistochemical analysis of early diabetic retinopathy. Appl Spectrosc 2009; 63:1336-1342.

Zhang JF, Wu YL, Xu JY, Ye W, Zhang Y, Weng H, Shi WD, Xu GX, Lu L, Dai W, Sinclair SH, Li W*, Xu G-T*: Pharmacokinetic and toxicity study of intravitreal erythropoietin in rabbits. Acta Pharmacol Sin 2008; 29:1383-1390. (*Co-corresponding authors)

Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W*, Xu G-T*: Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 2008; 49:732-742. (*Co-corresponding authors)

Wang Z, Xu G, Wu Y, Liu S, Sun B, Dai Q: Neuregulin-1 promotes cardiomyocyte differentiation of genetically engineered embryonic stem cell clones. BMB Rep 2008; 41:699-704.

Guo TB, Lu J, Li T, Lu Z, Xu G-T, Xu M, Lu L, Dai W: Insulin-activated, K+-channel-sensitive Akt pathway is primary mediator of ML-1 cell proliferation. Am J Physiol Cell Physiol 2005; 289:C257-263.

Cammarata PR, Xu G-T, Huang L, Zhou C, Martin M. Inducible expression of Na+/myo-inositol cotransporter mRNA in anterior epithelium of bovine lens: affiliation with hypertonicity and cell proliferation. Exp Eye Res. 1997; 64:745-57. 

.Lou MF, Xu G-T, Zigler S Jr, York B Jr. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors. Curr Eye Res. 1996; 15:423-32. 

.Lou MF, Xu G-T, Cui XL. Further studies on the dynamic changes of glutathione and protein-thiol mixed disulfides in H2O2 induced cataract in rat lenses: distributions and effect of aging. Curr Eye Res 1995; 14:951-8. 

Xu G-T, Zigler JS, Lou MF. Establishment of a naphthalene cataract model in vitro. Exp Eye Res 1992; 54:73-81. 

Xu G-T, Zigler JS Jr, Lou MF. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576). Exp Eye Res. 1992 Jan, 54(1):63-72. 

Russell P, Yamada T, Xu GT, Garland D, Zigler JS Jr. Effects of naphthalene metabolites on cultured cells from eye lens. Free Radic Biol Med. 1991; 10:255-61. 

Xu Guo-Tong. Progress in Stem Cell Research in China. Trends in Bio/Pharmaceutical Industry 2008; 4(1):35-40 (invited review)